Tenax Therapeutics (TENX) News Today $6.41 0.00 (0.00%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$6.39 -0.02 (-0.31%) As of 09/19/2025 05:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TENX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Tenax announces EPO intention to grant patent for levosimendan in PH-HFpEFSeptember 16, 2025 | msn.comTenax Therapeutics Secures European Patent Protection for TNX-103 and Levosimendan Formulations Until December 2040September 16, 2025 | quiverquant.comQTenax Therapeutics Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEFSeptember 16, 2025 | globenewswire.comTenax Therapeutics, Inc. (NASDAQ:TENX) Receives Average Rating of "Buy" from AnalystsSeptember 13, 2025 | americanbankingnews.comTenax Therapeutics (NASDAQ:TENX) Coverage Initiated at Piper SandlerSeptember 10, 2025 | americanbankingnews.comTenax Therapeutics initiated with an Overweight at Piper SandlerSeptember 9, 2025 | msn.comPiper Sandler Initiates Coverage of Tenax Therapeutics (TENX) with Overweight RecommendationSeptember 9, 2025 | msn.comTenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025August 28, 2025 | globenewswire.comTenax Therapeutics reports Q2 EPS (27c), consensus (45c)August 14, 2025 | msn.comTenax Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate UpdateAugust 13, 2025 | globenewswire.comTENX Tenax Therapeutics, Inc. - Seeking AlphaJune 24, 2025 | seekingalpha.comTenax Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate UpdateMay 14, 2025 | globenewswire.comTenax Therapeutics Inc.May 9, 2025 | barrons.comTenax: Phase 3 Heart Failure Program Continues With 2 Key CatalystsApril 16, 2025 | seekingalpha.comTenax Therapeutics files to sell 4.14M shares of common stock for holdersApril 16, 2025 | markets.businessinsider.comTenax Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare ConferenceMarch 31, 2025 | globenewswire.comTenax Therapeutics reports Q4 EPS (18c), consensus (43c)March 27, 2025 | markets.businessinsider.comTenax Therapeutics (TENX) Gets a Buy from William BlairMarch 27, 2025 | markets.businessinsider.comTenax Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate UpdateMarch 25, 2025 | globenewswire.comTenax Therapeutics Inc TENXMarch 14, 2025 | morningstar.comMRoth MKM Reaffirms Their Buy Rating on Tenax Therapeutics (TENX)March 6, 2025 | markets.businessinsider.comTenax Therapeutics expands Phase 3 LEVEL program for TNX-103March 5, 2025 | markets.businessinsider.comTenax Therapeutics prices 378,346 shares at $6.04 in private placementMarch 5, 2025 | markets.businessinsider.comTenax Therapeutics Announces $25 Million Private PlacementMarch 5, 2025 | globenewswire.comTenax Therapeutics Expands Phase 3 LEVEL Program, Advancing Two TNX-103 (Oral Levosimendan) Registrational Studies for the Treatment of PH-HFpEFMarch 5, 2025 | globenewswire.comTenax Therapeutics to Participate in the Leerink Partners 2025 Global Healthcare ConferenceMarch 3, 2025 | markets.businessinsider.comTenax Therapeutics to Participate in the Guggenheim SMID Cap Biotech ConferenceJanuary 31, 2025 | globenewswire.comTenax Therapeutics, Inc. Common Stock (TENX) Insider ActivityJanuary 28, 2025 | nasdaq.comTenax Therapeutics Appoints Gillian Andor Vice President, Clinical OperationsJanuary 22, 2025 | markets.businessinsider.comWill Tenax Therapeutics (NASDAQ:TENX) Spend Its Cash Wisely?December 5, 2024 | finance.yahoo.comTenax Therapeutics Appoints Interim CFO Thomas McGauleyDecember 4, 2024 | tipranks.comTenax Therapeutics, Inc. (TENX) Guggenheim Healthcare Innovation Conference (Transcript)November 15, 2024 | seekingalpha.comTenax Therapeutics reports Q3 EPS 19c, consensus ($1.39)November 14, 2024 | markets.businessinsider.comTenax Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate UpdateNovember 13, 2024 | globenewswire.comTenax Therapeutics Expands Stock Incentive PlanOctober 31, 2024 | markets.businessinsider.comTenax Therapeutics to Present at the Guggenheim Healthcare Innovation ConferenceOctober 31, 2024 | globenewswire.comTenax Therapeutics initiated with an Outperform at LeerinkOctober 25, 2024 | markets.businessinsider.comLeerink Partners Initiates Coverage of Tenax Therapeutics (TENX) with Outperform RecommendationOctober 25, 2024 | msn.comGuggenheim Initiates Coverage of Tenax Therapeutics (TENX) with Buy RecommendationOctober 15, 2024 | msn.comWilliam Blair Initiates Coverage of Tenax Therapeutics (TENX) with Outperform RecommendationOctober 2, 2024 | msn.comTENX: $100 Million Capital RaiseAugust 23, 2024 | finance.yahoo.comTenax Therapeutics, Inc. (TENX)August 15, 2024 | nz.finance.yahoo.comTenax Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate UpdateAugust 14, 2024 | finance.yahoo.comTENX Stock Earnings: Tenax Therapeutics Beats EPS for Q2 2024August 13, 2024 | investorplace.comTenax Therapeutics Announces Closing of $100 Million Private Placement and Plans to Accelerate the Oral Levosimendan Phase 3 ProgramAugust 12, 2024 | finance.yahoo.com3 Penny Stocks to Watch Now, 8/8/24August 8, 2024 | msn.comPound trades at five-week low on dollar, resumes recent slideAugust 7, 2024 | uk.finance.yahoo.comInvestor Sentiment Recovers as Recession Fears Wane, Driving Premarket Gains for US Equity FuturesAugust 7, 2024 | msn.comBiotech Soars Following Oversubscribed $100M Private Placement AnnouncementAugust 6, 2024 | msn.comWhy Is Tenax Therapeutics (TENX) Stock Up 29% Today?August 6, 2024 | investorplace.com Get Tenax Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TENX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TENX Media Mentions By Week TENX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TENX News Sentiment▼0.680.78▲Average Medical News Sentiment TENX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TENX Articles This Week▼31▲TENX Articles Average Week Get the Latest News and Ratings for TENX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Tenax Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Equillium News Fate Therapeutics News Atossa Genetics News Zentalis Pharmaceuticals News Spero Therapeutics News Adagene News Alto Neuroscience News HilleVax News MEI Pharma News VistaGen Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TENX) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tenax Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tenax Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
